Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intrathecal baclofen in children with dystonic cerebral palsy
2008-000833-23Phase 4Completed
- Sponsor
- Istituti Clinici di Perfezionamento
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of baclofen in dystonic cerebral palsy and cerebral palsy (CP) (2 arms), sponsored by Istituti Clinici di Perfezionamento. Primary endpoint: BAD total score improvement at 3 months. Started Nov 2008; status: completed.
02
Drugs
baclofen
03
Conditions
dystonic cerebral palsycerebral palsy (CP)
Beyond the preview
Go deeper on 2008-000833-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000833-23.